The study of the correlation between body mass index and colorectal cancer mechanism

doi:10.3877/cma.j.issn.2095-3224.2015.03.06

Abstract

Abstract:

Overweight or obesity is a pathologic status.Recently, obesity is known as one of the risk factors of several kinds of tumors including colorectal cancer.Some studies showed that fat tissue could secrete some factors relevant to the development and progress of colorectal cancer.This review article introduced the pathophysiological status of obesity and the correlation between relevant factors and the molecular mechanism of colorectal cancer.

Key words: Obesity, Colorectal Neoplasms, Molecular Mechanisms of Action

Ying-gang CHEN. The study of the correlation between body mass index and colorectal cancer mechanism[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2015, 04(03): 250-253.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhjzcjbdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-3224.2015.03.06

https://zhjzcjbdzzz.cma-cmc.com.cn/EN/Y2015/V04/I03/250

References 27

[1]	李立明，饶克勤，孔灵芝，等．中国居民2002年营养与健康状况调查．中华流行病学杂志，2005，26(7): 478-484.
[2]	Zheng S, Cai SR.Colorectal cancer epidemiology andprevention study in China.The Chinese-German Journal of Clinical Oncology, 2003, 2(2): 72-76.
[3]	Pischon T, Lahmann PH, Boeing H, et al.Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition(EPIC). J Natl Cancer Inst, 2006, 98(13): 920-931.
[4]	Sedjo RL, Byers T, Levin TR, et al.Change in body size and the risk of colorectal adenomas.Cancer Epidemiol Biomarkers Prev, 2007, 16(3): 526-531.
[5]	Cowey SL, Quast M, Belalcazar LM, et al.Abdominal obesity, insulin resistance, and colon carcinogenesis are increased in mutant mice lacking gastrin gene expression.Cancer, 2005, 103(12): 2643-2653.
[6]	Watkins LF, Lewis LR, Levine AE.Characterization of the synergistic effect of insulin and transferrin and the regulation of their receptors on a human colon carcinoma cell line.Int J Cancer, 1990, 45(2): 372-375.
[7]	Guo YS, Narayan S, Yallampalli C, et al.Characterization of insulinlike growth factor Ⅰ receptors in human colon cancer.Gastroenterology, 1992, 102(4Pt 1): 1101-1108.
[8]	Esposito K, Nappo F, Marfella R, et al.Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress.Circulation, 2002, 106(16): 2067-2072.
[9]	Eaden JA, Abrams KR, Mayberry JF.The risk of colorectal cancer in ulcerative colitis: a meta-analysis.Gut, 2001, 48(4): 526-535.
[10]	Yan SR, Joseph RR, Rosen K, et al.Activation of NFkappaB following detachment delays apoptosis in intestinal epithelial cells.Oncogene, 2005, 24(43): 6482-6491.
[11]	Chapkin RS, Davidson LA, Ly L, et al.Immunomodulatory effects of(n-3)fatty acids: putative link to inflammation and colon cancer.J Nutr, 2007, 137(1 Suppl): 200-204.
[12]	Zhang Y, Proenca R, Maffei M, et al.Positional cloning of the mouse obese gene and its human homologue.Nature, 1994, 372(6505): 425-432.
[13]	Isse N, Ogawa Y, Tamura N, et al.Structural organization and chromosomal assignment of the human obese gene.J Biol Chem, 1995, 270(46): 27728-27733.
[14]	Stattin P, Lukanova A, Biessy C, et alObesity and colon cancer: does leptin provide a link? .Int J Cancer, 2004, 109(1): 149-152.
[15]	Hardwick JC, Van Den Brink GR, Offerhaus GJ, et al.Leptin is a growth factor for colonic epithelial cells.Gastroenterology, 2001, 121(1): 79-90.
[16]	Rouet-Benzineb P, Aparicio T, Guilmeau S, et al.Leptin counteracts sodium butyrate-induced apoptosis in human colon cancer HT-29 cells via NF-kappaB signaling.J Biol Chem, 2004, 279(16): 16495-16502.
[17]	Attoub S, Noe V, Pirola L, et al.Leptin promotes invasiveness of kidney and colonic epithelial cells via phosphoinositide 3-kinase-, rho-, and rac-dependent signaling pathways.FASEB J, 2000, 14(14): 2329-2338.
[18]	Hoda MR, Keely SJ, Bertelsen LS, et al.Leptin acts as a mitogenic and antiapoptotic factor for colonic cancer cells.Br J Surg, 2007, 94(3): 346-354.
[19]	Garofalo C, Surmacz E. Leptin and cancer.J Cell Physiol, 2006, 207(1): 12-22.
[20]	Culig Z, Steiner H, Bartsch G, et al.Interleukin-6 regulation of prostate cancer cell growth.J Cell Biochem, 2005, 95(3): 97-505.
[21]	Fenton JI, Hursting SD, Perkins SN, et al.Interleukin-6 production induced by leptin treatment promotes cell proliferation in an Apc(Min/＋)colon epithelial cell line.Carcinogenesis, 2006, 27(7): 1507-1515.
[22]	Koji H, Saki I, Kojiro M. NF-κB-p65 dependent transcriptional regulation of glycosyltransferases in human colon adenocarcinoma HT-29 by stimulation with tumor necrosis factor-α.Biol Pharm Bull, 2006, 29(12): 2372-2377.
[23]	Zins K, Abraham D, Sioud M, et al.Colon cancer cellderived tumor necrosis factor-alpha mediates the tumor growth-promoting response in macrophages by upregulating the colony-stimulating factor-1 pathway.Cancer Res, 2007, 67(3): 1038-1045.
[24]	Petak I, Danam RP, Tillman DM, et al.Hypermethylation of the gene promoter and enhancer region can regulate Fas expression and sensitivity in colon carcinoma.Cell Death Differ, 2003, 10(2): 211-217.
[25]	Wolf I, Sadetzki S, Kanety H, et al.Adiponectin, ghrelin, and leptin in cancer cachexia in breast and colon cancer patients.Cancer, 2006, 106(4): 966-973.
[26]	Dignam JJ, Polite BN, Yothers G, et al.Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer.J Natl Cancer Inst, 2006, 98(22): 1647-1654.
[27]	Haydon AM, Macinnis RJ, English DR, et al.Effect of physical activity and body size on survival after diagnosis with colorectal cancer.Gut, 2006, 55(1)62-67.

Please choose a citation manager

Content to export